238 related articles for article (PubMed ID: 24990151)
21. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.
Carvalho RL; Itoh F; Goumans MJ; Lebrin F; Kato M; Takahashi S; Ema M; Itoh S; van Rooijen M; Bertolino P; Ten Dijke P; Mummery CL
J Cell Sci; 2007 Dec; 120(Pt 24):4269-77. PubMed ID: 18029401
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate downstream targets of TGFβ signaling during palate development by genome-wide transcript profiling.
Pelikan RC; Iwata J; Suzuki A; Chai Y; Hacia JG
J Cell Biochem; 2013 Apr; 114(4):796-807. PubMed ID: 23060211
[TBL] [Abstract][Full Text] [Related]
23. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints.
Seo HS; Serra R
Dev Biol; 2007 Oct; 310(2):304-16. PubMed ID: 17822689
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
25. Disruption of Foxg1 expression by knock-in of cre recombinase: effects on the development of the mouse telencephalon.
Eagleson KL; Schlueter McFadyen-Ketchum LJ; Ahrens ET; Mills PH; Does MD; Nickols J; Levitt P
Neuroscience; 2007 Aug; 148(2):385-99. PubMed ID: 17640820
[TBL] [Abstract][Full Text] [Related]
26. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
[TBL] [Abstract][Full Text] [Related]
27. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
29. Smad4-Irf6 genetic interaction and TGFβ-mediated IRF6 signaling cascade are crucial for palatal fusion in mice.
Iwata J; Suzuki A; Pelikan RC; Ho TV; Sanchez-Lara PA; Urata M; Dixon MJ; Chai Y
Development; 2013 Mar; 140(6):1220-30. PubMed ID: 23406900
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
[TBL] [Abstract][Full Text] [Related]
31. Tgfbr2 is required for development of the skull vault.
Seo HS; Serra R
Dev Biol; 2009 Oct; 334(2):481-90. PubMed ID: 19699732
[TBL] [Abstract][Full Text] [Related]
32. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
33. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
[TBL] [Abstract][Full Text] [Related]
34. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects.
Ito Y; Yeo JY; Chytil A; Han J; Bringas P; Nakajima A; Shuler CF; Moses HL; Chai Y
Development; 2003 Nov; 130(21):5269-80. PubMed ID: 12975342
[TBL] [Abstract][Full Text] [Related]
35. A Type 2 Deiodinase-Dependent Increase in
An X; Ogawa-Wong A; Carmody C; Ambrosio R; Cicatiello AG; Luongo C; Salvatore D; Handy DE; Larsen PR; Wajner SM; Dentice M; Zavacki AM
Thyroid; 2021 Jan; 31(1):115-127. PubMed ID: 32787533
[No Abstract] [Full Text] [Related]
36. TGFbeta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development.
Sasaki T; Ito Y; Bringas P; Chou S; Urata MM; Slavkin H; Chai Y
Development; 2006 Jan; 133(2):371-81. PubMed ID: 16368934
[TBL] [Abstract][Full Text] [Related]
37. Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier.
Reyahi A; Nik AM; Ghiami M; Gritli-Linde A; Pontén F; Johansson BR; Carlsson P
Dev Cell; 2015 Jul; 34(1):19-32. PubMed ID: 26120030
[TBL] [Abstract][Full Text] [Related]
38. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
Correia AC; Moonen JR; Brinker MG; Krenning G
J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
[TBL] [Abstract][Full Text] [Related]
39. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis.
Ma H; Pan JS; Jin LX; Wu J; Ren YD; Chen P; Xiao C; Han J
Cancer Lett; 2016 Jul; 376(2):293-302. PubMed ID: 27080303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
